Ivana Magovcevic-Liebisch
CIK 1279281 · President and CEO · last filed 2026-05-20
Ivana Magovcevic-Liebisch is a President and CEO who has filed 55 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for ACRV, was dated May 20, 2026. Across all open-market trades the lifetime net is −$882.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $149.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$149.0K
7
55
-$882.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACRV | Director | 9,366 | $1.48 | $13.9K | $0 | 3 | 2026-05-20 |
| QTRX | Director | 43,607 | $3.10 | $135.2K | $0 | 3 | 2026-01-15 |
| Vigil Neuroscience, Inc. (VIGL) Delisted | President and CEO | 0 | $8.05 | $0 | $61.8K | 11 | 2025-08-05 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Director | — | $12.01 | — | $0 | 6 | 2023-06-30 |
| ABSI | Director | — | $6.80 | — | $0 | 1 | 2022-06-10 |
| APPLIED GENETIC TECHNOLOGIES CORP (AGTC) Delisted | Director | 3,000 | $0.39 | $1.2K | $28.9K | 11 | 2021-12-02 |
| DYAX CORP (DYAX) Delisted | EVP; Chief Operating Officer | 255,984 | — | — | -$972.7K | 20 | 2013-03-29 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-20 | ACRV | Grant (A) | +9,366 | $0 | EDGAR |
| 2026-01-15 | QTRX | Grant (A) | +23,372 | $0 | EDGAR |
| 2025-08-05 | Vigil Neuroscience, Inc. (VIGL) Delisted | Disp (D) | −222,687 | $0 | EDGAR |
| 2025-06-17 | ACRV | Grant (A) | — | $0 | EDGAR |
| 2025-03-04 | Vigil Neuroscience, Inc. (VIGL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-06 | QTRX | Grant (A) | +7,435 | $0 | EDGAR |
| 2024-12-19 | Vigil Neuroscience, Inc. (VIGL) Delisted | Buy (P) | +5,000 | $8.4K | EDGAR |
| 2024-12-18 | Vigil Neuroscience, Inc. (VIGL) Delisted | Buy (P) | +5,000 | $8.3K | EDGAR |
| 2024-12-05 | Vigil Neuroscience, Inc. (VIGL) Delisted | Buy (P) | +5,000 | $11.7K | EDGAR |
| 2024-10-03 | QTRX | Grant (A) | +12,800 | $0 | EDGAR |